Kun Zhang
Directeur/Bestuurslid bij SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Vermogen: 3 M $ op 30-04-2024
Actieve functies van Kun Zhang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Directeur/Bestuurslid | 20-04-2018 | - |
| Corporate Officer/Principal | 20-04-2018 | - |
Loopbaan van Kun Zhang
Eerdere bekende functies van Kun Zhang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Essen Technology (Beijing) Co., Ltd.
 Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01-11-2014 | 01-10-2020 |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Verkoop & Marketing | 01-05-2009 | 01-01-2011 |
| MICROPORT SCIENTIFIC CORPORATION | Verkoop & Marketing | 01-05-2002 | 01-03-2004 |
Opleiding van Kun Zhang
| Academy of Armored Forces Engineering | Undergraduate Degree |
| City University of Hong Kong | Masters Business Admin |
Statistieken
Internationaal
| China | 5 |
| Kaaimaneilanden | 2 |
| Hongkong | 2 |
Operationeel
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| MICROPORT SCIENTIFIC CORPORATION | Health Technology |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Health Technology |
